Can I ask, then, how you make decisions about dosage for, say, young children less than three years of age, when GSK's own report says there is no data, no experience in children less than three years of age, and also with respect to elderly people? And I could go through the list.
In regard to pregnant women, “No data have been generated in pregnant women with Arepanrix™ H1N1 nor with the prototype ASO3 adjuvanted H5N1 vaccine.”